Detection and Quantification of VEGF Isoforms by ELISA

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Vascular endothelial growth factor (VEGF) is crucial for angiogenesis in both physiological and tumor contexts.
• Alternative RNA splicing of the human VEGF gene produces various isoforms, with VEGF121 and VEGF165 being the most prevalent.
• The distinct biological roles of VEGF isoforms remain incompletely understood, necessitating methods for their specific detection.

Purpose of the Study:

• To develop and validate a set of enzyme-linked immunosorbent assays (ELISAs) for quantifying specific vascular endothelial growth factor (VEGF) isoforms.
• To enable the assessment of VEGF121, VEGF165, and VEGF110 concentrations in biological samples.
• To facilitate research into the differential functions of VEGF isoforms and their potential as predictive biomarkers for anti-angiogenic therapies.

Main Methods:

• Utilized antibodies targeting distinct epitopes on VEGF165 to create three specific ELISAs.
• The first ELISA quantifies VEGF165.
• The second ELISA detects both VEGF121 and VEGF165, while the third detects VEGF165, VEGF121, and VEGF110.

Main Results:

• Developed a strategy to quantify VEGF121 by subtracting the signal from the first ELISA from the second.
• Enabled the measurement of VEGF110 by calculating the difference between the third and second ELISAs.
• Demonstrated the feasibility of quantifying specific VEGF isoforms using a differential ELISA approach.

Conclusions:

• Established a novel ELISA-based methodology for the precise quantification of VEGF121 and VEGF110 isoforms.
• This approach overcomes the limitation of lacking isoform-specific monoclonal antibodies.
• The assay strategy holds potential for analyzing other VEGF isoforms with the availability of appropriate antibodies.